Diffusion-weighted imaging in brain aspergillosis

M Charlot1, J-B Pialat, N Obadia

  • 1Department of Radiology, Claude Bernard University, Hospices Civils de Lyon, Lyon, France.

Insights

Diffusion-weighted imaging (DWI) reveals characteristic patterns in brain aspergillosis, aiding early diagnosis. These findings help differentiate fungal infections from other brain lesions in immunocompromised patients.

Area of Science:

  • Neurology
  • Radiology
  • Infectious Diseases

Background:

  • Brain aspergillosis is a rare, severe infection primarily affecting immunocompromised individuals, often causing cerebral infarctions.
  • Magnetic resonance (MR) imaging is used to diagnose brain aspergillosis, but diffusion-weighted imaging (DWI) findings, particularly in non-enhancing lesions, are less understood.
  • Early diagnosis is crucial for timely antifungal treatment to improve patient outcomes.

Observation:

  • This study analyzed MR imaging, including DWI and apparent diffusion coefficient (ADC) mapping, in three patients with brain aspergillosis.
  • A total of 23 circular lesions were observed across the patients, with one also showing an infarction in the middle cerebral artery territory.
  • Lesions exhibited varied enhancement patterns: one ring-enhancing, two non-enhancing.

Findings:

  • Eleven lesions showed high signal intensity on DWI with reduced ADC values.
  • Twelve lesions displayed a 'target-like' appearance on DWI, with central and peripheral hypointense areas (higher ADC) and intermediate hypersignal.
  • This 'target-like' DWI appearance is a typical finding in brain aspergillosis.

Implications:

  • The characteristic DWI 'target-like' sign can facilitate early diagnosis of brain aspergillosis.
  • This imaging finding is valuable for differentiating aspergillosis from other infectious or malignant brain lesions in immunocompromised patients.
  • Earlier diagnosis via DWI may enable prompt initiation of antifungal therapy, potentially improving prognosis.